Status:
UNKNOWN
Study on Optimal Oxygen Concentration During Pulmonary Rehabilitation
Lead Sponsor:
National Hospital Organization Minami Kyoto Hospital
Conditions:
High-flow Nasal Cannula
Exercise Capacity
Eligibility:
All Genders
20-90 years
Phase:
NA
Brief Summary
The purpose of this study is to compare the exercise capacity between high SpO2 (Minimum SpO2 94-96%) value during pulmonary rehabilitation and low SpO2 (Minimum SpO2 84-86%) value during pulmonary re...
Detailed Description
In patients with chronic respiratory failure, pulmonary rehabilitation is recognized as an evidence-based treatment in improving exercise capacity, muscle strength, dyspnea, and quality of life. Howev...
Eligibility Criteria
Inclusion
- Subjects with chronic respiratory failure receiving long-term oxygen therapy for more than 3 months.
Exclusion
- Subjects with severe cardiovascular disease, liver disease, neurological disease, and renal failure.
- Subjects with a history of hospitalization for pneumonia or exacerbation of respiratory failure within the last month.
- Subjects with changes in LTOT prescription flow within the last month
- Subjects who cannot undergo pulmonary rehabilitation due to severe heart failure, arteriosclerosis obliterans or spinal disease.
Key Trial Info
Start Date :
July 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04481295
Start Date
July 18 2020
End Date
July 1 2025
Last Update
March 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Hospital Organization Minami Kyoto Hospital
Jōyō, Kyoto, Japan, 610-0113